Inventor
YOUNGMAN MARK A
US30 patents
⚠️ This page may combine multiple inventors who share the name “YOUNGMAN MARK A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE PHARMA LP
12 patentsUS9273048B2Mar 1, 2016
Spirocyclic morphinans and their use
PURDUE PHARMA LP11 citations84
US9175000B2Nov 3, 2015
Buprenorphine analogs
PURDUE PHARMA LP11 citations84
US8987287B2Mar 24, 2015
Spirocyclic morphinans and their use
PURDUE PHARMA LP15 citations84
US9403824B2Aug 2, 2016
Pyridonemorphinan analogs and biological activity on opioid receptors
PURDUE PHARMA LP8 citations83
US10059675B2Aug 28, 2018
Pyrimidines as sodium channel blockers
PURDUE PHARMA LP2 citations73
US11180502B2Nov 23, 2021
Azaspiro[4.5]decane derivatives and use thereof
PURDUE PHARMA LP0 citations62
US10774050B2Sep 15, 2020
Pyrimidines as sodium channel blockers
PURDUE PHARMA LP0 citations52
US10030021B2Jul 24, 2018
Spirocyclic morphinans and use thereof
PURDUE PHARMA LP0 citations52
US9884865B2Feb 6, 2018
Azaspiro[4.5] decane derivatives and use thereof
PURDUE PHARMA LP0 citations52
US10196364B2Feb 5, 2019
Pyrimidine carboxamides as sodium channel blockers
PURDUE PHARMA LP0 citations51
US10131666B2Nov 20, 2018
Heterocyclic morphinan derivatives and use thereof
PURDUE PHARMA LP0 citations42
US10550088B2Feb 4, 2020
6-substituted and 7-substituted morphinan analogs and the use thereof
PURDUE PHARMA LP0 citations41
JANSSEN PHARMACEUTICA NV
5 patentsUS7951829B2May 31, 2011
Benzimidazole modulators of VR1
JANSSEN PHARMACEUTICA NV6 citations60
US7897781B2Mar 1, 2011
Cold menthol receptor-1 antagonists
JANSSEN PHARMACEUTICA NV6 citations60
US9096521B2Aug 4, 2015
Cold menthol receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations51
US9434711B2Sep 6, 2016
Sulfonamides as TRPM8 modulators
JANSSEN PHARMACEUTICA NV0 citations49
US9090639B2Jul 28, 2015
Cold menthol receptor-1 antagonists
JANSSEN PHARMACEUTICA NV0 citations49
ORTHO MCNEIL PHARM INC
4 patentsUS6140354AOct 31, 2000
N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
ORTHO MCNEIL PHARM INC152 citations98
US7358261B2Apr 15, 2008
Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ORTHO MCNEIL PHARM INC17 citations92
US6201025B1Mar 13, 2001
N-aralkylaminotetralins as ligands for the neuropeptide Y Y5 receptor
ORTHO MCNEIL PHARM INC35 citations92
US6958349B2Oct 25, 2005
Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ORTHO MCNEIL PHARM INC5 citations62
COLBURN RAYMOND W
4 patentsUS8653099B2Feb 18, 2014
Cold menthol receptor antagonists
COLBURN RAYMOND W9 citations82
US8324217B2Dec 4, 2012
Cold menthol receptor antagonists
COLBURN RAYMOND W13 citations82
US8143259B2Mar 27, 2012
Cold menthol receptor antagonists
COLBURN RAYMOND W13 citations82
US8629281B2Jan 14, 2014
Cold menthol receptor-1 antagonists
COLBURN RAYMOND W0 citations48